NAMS
NASDAQ · Biotechnology
Newamsterdam Pharma Co Nv
$31.01
+0.95 (+3.16%)
Performance
1D
—
1W
—
1M
—
3M
-12.08%
6M
+12.68%
1Y
+37.46%
YTD
-11.90%
Open$30.97
Previous Close$30.06
Day High$32.04
Day Low$30.52
52W High$42.00
52W Low$14.06
Volume—
Avg Volume728.6K
Market Cap3.93B
P/E Ratio—
EPS$-2.02
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$34.11
Below
SMA 200
$28.53
Above
RSI (14)
66.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+17.3% upside
Current
$31.01
$31.01
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 53.10M | 2.67B | 2.72B |
| Net Income | -281,545,298 | 178.81M | 249.35M |
| Profit Margin | -530.3% | 6.7% | 9.2% |
| EBITDA | -293,399,142 | 313.99M | 355.91M |
| Free Cash Flow | — | 105.97M | 147.67M |
| Rev Growth | — | +5.8% | +24.9% |
| Debt/Equity | — | 0.69 | 0.72 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |